Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hisamitsu Pharmaceutical Co ( (JP:4530) ) has issued an update.
Hisamitsu Pharmaceutical Co. has finalized the details of stock compensation-type share options, initially resolved by the Board of Directors on July 10, 2025. The allocation involves 141 stock acquisition rights priced at 318,600 yen each, calculated using the Black-Scholes model based on the Tokyo Stock Exchange’s closing price. These rights are designated for six directors of the company, excluding outside directors, and are intended to align their interests with the company’s performance.
More about Hisamitsu Pharmaceutical Co
YTD Price Performance: -1.50%
Average Trading Volume: 157,206
Technical Sentiment Signal: Sell
Current Market Cap: Yen290.5B
For detailed information about 4530 stock, go to TipRanks’ Stock Analysis page.